Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.
2015 article from Nature Reviews Urology.
Among the panel are Dr Lamm and Dr O'Donnell, among other recognized names.
Of major interest is a comparison of BCG maintenance schedules and outcomes. THIS IS GOOD STUFF.
Table I shows in graphic format the comparison, but dont mess the text.
COMMENTS ?
www.nature.com/nrurol/journal/v12/n4/full/nrurol.2015.58.html
Best
Jack
